ADHD Drug Safety In Adults Still Under Review After FDA Gives Kids Cardiac Thumbs Up
This article was originally published in The Pink Sheet Daily
Observational study sponsored by FDA and AHRQ showed no association between the use of certain ADHD medications and CV events in children.
You may also be interested in...
Agency awaits two additional observational studies after acknowledging that a study it funded has methodological flaws.
Manufacturers have 30 days to comply with FDA's request, Division of Psychiatry Products Director Laughren says.
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.